USING FORXIGA IN T1D

FORXIGA 5 mg OFFERS CONVENIENT, ONCE-DAILY ORAL DOSING IN ADULTS WITH TYPE 1 DIABETES (T1D), AS AN ADJUNCT TO INSULIN1*

5 mg
ORAL DOSE

ONCE
DAILY

*In the EU.

BEFORE INITIATING FORXIGA:

In order to avoid hypoglycaemia with the first dose of Forxiga, consider a 20% reduction in the first mealtime bolus insulin.
No reduction in basal insulin is recommended when initiating Forxiga. Subsequently, bolus and basal insulin doses should be adjusted based on blood glucose results. When needed, insulin dose reduction should be done cautiously to avoid ketosis and diabetic ketoacidosis.

-

Treatment with Forxiga 5 mg is to be initiated and supervised by specialists in T1D.

-

Forxiga should not be initiated in patients with a glomerular filtration rate (GFR) <60 mL/min and should be discontinued at GFR persistently below 45 mL/min.

References:

  1. Forxiga. Summary of Product Characteristics. 2019. AstraZeneca.
Back to top